Stocktoria
Equillium, Inc. EQ
Equillium, Inc. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $41.1M | $36.1M | $15.8M | — | — | — | — |
| R&D expense | — | — | $37.0M | $37.5M | $26.4M | $19.4M | $17.6M | $4.9M |
| Operating income | -$23.6M | -$8.3M | -$14.5M | -$62.1M | -$37.8M | -$29.5M | -$26.7M | -$8.6M |
| Income tax | $0 | $361,000 | $580,000 | $0 | $0 | $0 | — | — |
| Net income | -$22.4M | -$8.1M | -$13.3M | -$62.4M | -$39.1M | -$29.8M | -$25.6M | -$13.2M |
| EPS (diluted) | $-0.39 | $-0.23 | $-0.38 | $-1.85 | $-1.36 | — | — | — |
| Operating cash flow | -$22.7M | -$19.0M | -$21.8M | -$8.7M | -$32.1M | -$24.6M | -$22.9M | -$7.5M |
| Free cash flow | -$22.8M | -$19.1M | -$21.8M | -$9.0M | -$32.1M | -$24.8M | -$23.0M | -$7.6M |
| Cash & equivalents | $30.3M | $18.1M | $23.2M | $59.1M | $50.4M | $24.0M | $13.2M | $28.5M |
| Total assets | $31.9M | $25.6M | $50.5M | $78.4M | $85.4M | $85.4M | $55.5M | $67.2M |
| Total liabilities | $3.3M | $6.5M | $28.0M | $46.5M | $18.9M | $15.6M | $13.7M | $2.2M |
| Shareholders' equity | $28.6M | $19.1M | $22.6M | $31.9M | $66.5M | $69.9M | $41.8M | $64.9M |
Growth · year-over-year · Revenue CAGR 61.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | +13.9% | +129.0% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.